Fig. 1. Distribution of tetracycline labels (A) and MS/BS (B) in the TPTD and ZOL acid groups: values are medians (interquartile range). Representative.

Slides:



Advertisements
Similar presentations
Chapter 85 Chapter 85 Parathyroid Hormone Treatment for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

BOX PLOTS/QUARTILES. QUARTILES: 3 points in a set of data that separate the set into 4 equal parts. Lower Quartile: Q1 (The median for the lower half.
ECTS symposium 5 Anabolic treatment of osteoporosis.
The Median of a Continuous Distribution
Example Suppose that we take a random sample of eight fuel efficient cars and record the gas mileage. Calculate the following for the results: 33, 41,
Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.
Figure 2. ROC curves for fasting values (A) and OGTT values (B) for detecting insulin resistance in PCOS women. Sensitivity is plotted against 1 − specificity.
Figure 2. Summary of trial events
Figure 1. Twenty-four-hour plasma ACTH concentrations in insomniacs (▪) and controls (○). The thick black line indicates the sleep recording period. The.
Therapeutic Implications
Fig. 1. Baseline and 3-month infusion protocol
From: Perioperative Use of Dobutamine in Cardiac Surgery and Adverse Cardiac Outcome:Propensity-adjusted Analyses Anesthes. 2008;108(6): doi: /ALN.0b013e f.
Copyright © 2005 American Medical Association. All rights reserved.
Volume 48, Issue 4, Pages (April 2011)
Fig. 1. Time line for investigations
Fig. 1. Kaplan-Meir survival curves for Stoke Cushing's patients, with follow-up duration in years on the x-axis. Number of patients in each subgroup is.
Numbers correspond to section of text addressing selected clinical issue. From: Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice.
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs of the FTO gene. The P values are for the additive model.
Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.
Figure 2 Top panel shows mean (SE) differences in near-final height (cm) (n = 71) in the AI, GH, and AI/GH groups regardless of length of treatment (n.
Fig. 1. Study enrollment and disposition of participants
Copyright © 2004 American Medical Association. All rights reserved.
Figure 1. Illustrative 24-h serum LH concentration (IRMA) profiles and calculated LH secretory rates as determined by deconvolution analysis in one healthy.
Fig. 2. Plasma melatonin secretion profiles for each of the eight subjects across the three conditions in the study. Profiles are shown for the entire.
Fig. 1. Left, Total ghrelin; right, octanoylated ghrelin
Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447
Fig. 4. Single total plasma 8-isoprostane levels in both controls and type 2 diabetic patients. Diabetes Induces p66shc Gene Expression in Human Peripheral.
Figure 1. Circadian pattern of gastric pH in healthy control subjects documented before (P1) Ramadan, on the 10th day (P2) and on the 24th day (P3) of.
Figure 1. Consort flow diagram.
Chapter 67: Non-Parathyroid Hypercalcemia
Fig. 1. BAT activity before and after WL
Fig. 1. Effect of bariatric surgery on BMI and plasma leptin concentration. BMI (A) and plasma leptin concentrations (B) were determined in 27 morbidly.
Fig. 1. Flow of subjects through different phases of the study.
Quantified net intensity data are in arbitrary units (AU)
Fig. 1. Serum total cholesterol (A), LDL cholesterol (B), triglyceride (C) and HDL cholesterol level (D) according to HBsAg status in age group. Total.
Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal
From: Low Vitamin D Status despite Abundant Sun Exposure
HT (n = 45), healthy control subjects (HC) (n = 22), DTC-I, recurrent or persistent DTC (n = 27), DTC-II, disease free DTC (n = 34). Tg clusters are defined.
Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty.
Fig. 1. Mean plasma lipid and lipoprotein levels as a function of the common genetic variants in LCAT, g.-293G>A, S208T, and L369L in the CCHS and S208T.
Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.
Fig. 5. Histopathological study of the tumor tissue removed from patient 2. A, Macroscopic view of a tumor slice showing a dense tissue occupying the center.
Copyright © 2007 American Medical Association. All rights reserved.
Figure 1. Analysis of four different hPRLR mRNA isoforms (L, I, S1a, and S1b) in human breast adipose tissue (Breast AT), sc abdominal.
Figure 1. Summary of PTH secretion from human parathyroid cells after caffeine treatment at concentrations of 0, 1, 10, and 50 μm at extracellular calcium.
Figure 1. TAK-448 structure (A) and effect on the hypothalamic-pituitary-gonadal axis (B). At the normal physiological state, GnRH pulses in the hypothalamus.
Predicted values and SEs were based on linear mixed models
Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.
FIG. 1 Odds ratios (95% CIs) of metabolic syndrome and individual components calculated for clinical measures of periodontal disease (A and B). For gingival.
Figure 1. BRAF V600E mutation analysis in PTC
Fig. 3. Mean body weight of women randomized to low-carbohydrate and low-fat diets over the course of the 4-month trial. The first time point (wk 1) represents.
Longitudinal effects of aging on date-adjusted testosterone (T) and free testosterone index (free T index). Linear segment plots for total T and free T.
Figure 1. Height distribution for adults with AIS.
Figure 1. Serum concentrations of IGF-I (A), IGF-II (B), IGFBP-3 (C), and ALS (D) throughout life in GHD (closed circles) and healthy control (open circles)
From: Is Age a Risk Factor for Hypothyroidism in Pregnancy
Fig. 1. Trial profile. From: Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the.
Triangles and dotted lines are for mean values. , P <
Fig. 3. Plasma profiles of active GIP (A) and total GIP (B) concentrations after administration of single oral doses of sitagliptin 25 (white circles)
Fig. 4. Relationships of changes in CRP or SAA to changes in body weight and insulin resistance. For each comparison the regression line is shown (solid.
Figure 1. Correlations between TNFα and HOMA IR in men (•) and women (○). Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population.
Fig. 1. Serum levels of IGF-I vs
Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.
Risk Factors for the Development of Bone Metastases in Prostate Cancer
Vert Non-Vert Hip ** ** Zoledronic Acid3 Zoledronic Acid4 Denosumab5
Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.
Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled.
Volume 66, Issue 2, Pages (August 2004)
Figure 1. Randomization and dropouts.
Figure 1. Relative risks of vertebral, hip, and nonvertebral fractures (and 95% CIs) in response to the treatments for ... Figure 1. Relative risks of.
Presentation transcript:

Fig. 1. Distribution of tetracycline labels (A) and MS/BS (B) in the TPTD and ZOL acid groups: values are medians (interquartile range). Representative photomicrograph of tetracycline labels in cancellous bone from the ZOL (MS/BS = 0.20%) (C) and TPTD (MS/BS = 5.38%) (D) groups. From: Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial J Clin Endocrinol Metab. 2012;97(8):2799-2808. doi:10.1210/jc.2012-1262 J Clin Endocrinol Metab | Copyright © 2012 by The Endocrine Society

Fig. 2. MAR in the TPTD and ZOL groups: values are medians (interquartile range). MAR was calculated in four different ways. MAR 1, Double labels only. MAR 2, Double labels, single labels: MAR = 0.3 μm/d, no labels: MAR = zero. MAR 3, Double labels, single labels: MAR = missing, no labels: MAR = zero. MAR 4, Double labels, single labels: MAR = 0.3 μm/d, no labels: MAR = missing. From: Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial J Clin Endocrinol Metab. 2012;97(8):2799-2808. doi:10.1210/jc.2012-1262 J Clin Endocrinol Metab | Copyright © 2012 by The Endocrine Society

Fig. 3. Percentage change from baseline to month 12 (mean ± se) in serum P1NP and CTX for ZOL (A) and TPTD (B) (P < 0.001 for all between-group comparisons for change from baseline). C, Correlation of P1NP and MS/BS at month 6. From: Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial J Clin Endocrinol Metab. 2012;97(8):2799-2808. doi:10.1210/jc.2012-1262 J Clin Endocrinol Metab | Copyright © 2012 by The Endocrine Society

Fig. 4. Spider plots of dynamic (A) and static histomorphometric (B) parameters in the TPTD and ZOL groups: values are medians based on MAR 1 analyses. From: Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial J Clin Endocrinol Metab. 2012;97(8):2799-2808. doi:10.1210/jc.2012-1262 J Clin Endocrinol Metab | Copyright © 2012 by The Endocrine Society